Chief Scientific Officer · Candel Therapeutics, Inc. · Common Stock
Side
SELL
Value
$236K
Shares
23.4K
Price
$10.06
Executed
Jun 29, 2026
Disclosed
Jul 1, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 29 executedJul 1, 2026 disclosed
CADL · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Barone Francesca filed this Form 4 reporting a open-market sale of CADL on Jun 29, 2026. It became public on Jul 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Barone Francescacik:0001909680
Issuer
Candel Therapeutics, Inc.cik:0001841387
Revision history · 0
No field has changed since this record was first ingested.
